Advertisement

Advertisement

IVVD Stock Latest News

Invivyd completes enrollment of LIBERTY clinical trial

The FlyInvivyd completes enrollment of LIBERTY clinical trial

Shrader Reiterates Buy on Invivyd, Maintains $10 Price Target on Strong VYD2311 Prospects and High-Risk Population Opportunity

PremiumRatings

Shrader Reiterates Buy on Invivyd, Maintains $10 Price Target on Strong VYD2311 Prospects and High-Risk Population Opportunity

26d ago

Invivyd completes enrollment in DECLARATION trial

PremiumThe Fly

Invivyd completes enrollment in DECLARATION trial

26d ago

Invivyd: Buy Rating Reiterated as Clinical and Regulatory Progress Supports Unchanged $10 Price Target

PremiumRatings

Invivyd: Buy Rating Reiterated as Clinical and Regulatory Progress Supports Unchanged $10 Price Target

1M ago

Invivyd Shareholders Reelect Board, Ratify PwC Auditor

PremiumCompany Announcements

Invivyd Shareholders Reelect Board, Ratify PwC Auditor

1M ago

Invivyd management to meet with BTIG

PremiumThe FlyInvivyd management to meet with BTIG

1M ago

Invivyd Earnings Call Highlights Trial Progress, Growth

Company Announcements

Invivyd Earnings Call Highlights Trial Progress, Growth

1M ago

Invivyd post earnings selloff overdone, says H.C. Wainwright

The Fly

Invivyd post earnings selloff overdone, says H.C. Wainwright

1M ago

Invivyd Posts Strong Q1 Results, Advances VYD2311 Programs

PremiumCompany Announcements

Invivyd Posts Strong Q1 Results, Advances VYD2311 Programs

1M ago

IVVD Earnings this Week: How Will it Perform?

PremiumPre-Earnings

IVVD Earnings this Week: How Will it Perform?

2M ago

Invivyd annouces Chairman Elia to speak at POLITICO Health Care Summit

PremiumThe Fly

Invivyd annouces Chairman Elia to speak at POLITICO Health Care Summit

2M ago

Invivyd: Multi‑Virus Antibody Platform Progress and Pivotal COVID-19 Trial Support Buy Rating and $10 Target

PremiumRatings

Invivyd: Multi‑Virus Antibody Platform Progress and Pivotal COVID-19 Trial Support Buy Rating and $10 Target

3M ago

Midday Fly By: Ares to acquire Whitestone REIT, Disney to make ‘sizable’ layoffs

PremiumThe FlyMidday Fly By: Ares to acquire Whitestone REIT, Disney to make ‘sizable’ layoffs

3M ago

Invivyd provides update on Phase 3 DECLARATION study of VYD2311

The Fly

Invivyd provides update on Phase 3 DECLARATION study of VYD2311

3M ago

Invivyd announces discovery, advancement of measles antibody candidate VMS063

The Fly

Invivyd announces discovery, advancement of measles antibody candidate VMS063

3M ago

Invivyd Advances COVID-19 Program and Launches Measles Antibody

PremiumCompany Announcements

Invivyd Advances COVID-19 Program and Launches Measles Antibody

3M ago

Invivyd Earnings Call Highlights Pivotal Trial Momentum

PremiumCompany Announcements

Invivyd Earnings Call Highlights Pivotal Trial Momentum

4M ago

Invivyd: Accelerating PEMGARDA Uptake and Strong Cash Runway Position VYD2311 as a De‑Risked Growth Catalyst

PremiumRatings

Invivyd: Accelerating PEMGARDA Uptake and Strong Cash Runway Position VYD2311 as a De‑Risked Growth Catalyst

4M ago

Invivyd: Late‑Stage COVID-19 Antibody Progress and Solid Fundamentals Support Buy Rating

PremiumRatings

Invivyd: Late‑Stage COVID-19 Antibody Progress and Solid Fundamentals Support Buy Rating

4M ago

Invivyd Advances VYD2311 With Key Phase 3 Alignments

PremiumCompany AnnouncementsInvivyd Advances VYD2311 With Key Phase 3 Alignments

4M ago

Invivyd reports cash, cash equivalents of $226.7M as of December 31

The Fly

Invivyd reports cash, cash equivalents of $226.7M as of December 31

4M ago

Invivyd appoints Michael Mina as CMO

The Fly

Invivyd appoints Michael Mina as CMO

4M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >